Over-the-Counter Drugs Market Research Reports & Industry Analysis
Because most adults prefer to treat minor ailments themselves before seeking professional care, over-the-counter (OTC) drugs play an increasingly vital role in our healthcare system. MarketResearch.com’s comprehensive OTC drug market research reports provide full coverage of OTC drugs, including the cough remedy, contraceptive, and smoking cessation markets.
Over the Counter (OTC) Drugs Market Data
- Our reports focus on consumer health trends and developments and include data on OTC drug market segmentation, size, and growth in the U.S., U.K., Europe, Asia, and global markets.
- We also provide expert insights into category data, prospects and opportunities, the competitive landscape, and retailing developments.
- In addition, our research covers the growing demand for natural and herbal remedies, the increasing role of e-commerce, and the rise of self-care and preventive health practices.
Drive Growth Through Objective Research
The OTC drugs industry is a key segment of healthcare filled with promising opportunities. As you navigate this dynamic industry, let our reports be your guide, helping you make informed decisions and discover untapped avenues for growth. To get started, browse our collection of OTC drugs industry research reports today.
Over-the-Counter Drugs Industry Research & Market Reports
-
Menstrual Care in Mexico
... While all categories experienced current value growth, the magnitude varied by product type. Tampons showed the highest growth, followed by pantyliners and, finally, towels. Euromonitor International's Menstrual Care in Mexico report offers a comprehensive guide ... Read More
-
First Aid Supplies (UK) - Industry Report
... Seek out the most attractive acquisition opportunities • Analyse industry trends • Benchmark their own financial performance Using an exclusive methodology, a quick glance of this First Aid Supplies (UK) report will tell you the ... Read More
-
Child Resistant Closures
... at a CAGR of 4.2% over the analysis period 2024-2030. Push and Turn, one of the segments analyzed in the report, is expected to record a 4.4% CAGR and reach US$1.8 Billion by the end ... Read More
-
Tinea Pedis (Athlete`s Foot) Treatment
... Billion by 2030, growing at a CAGR of 3.0% over the analysis period 2024-2030. Topical, one of the segments analyzed in the report, is expected to record a 3.3% CAGR and reach US$756.3 Million by ... Read More
-
Ibuprofen API
... CAGR of 0.9% over the analysis period 2024-2030. Arthritis Application, one of the segments analyzed in the report, is expected to record a 1.4% CAGR and reach US$392.0 Million by the end of the analysis ... Read More
-
Condoms
... 5.8% over the analysis period 2024-2030. Natural, one of the segments analyzed in the report, is expected to record a 5.6% CAGR and reach US$9.2 Billion by the end of the analysis period. Growth in ... Read More
-
Foot Care Products
... at a CAGR of 5.5% over the analysis period 2024-2030. Foot Creams, one of the segments analyzed in the report, is expected to record a 5.2% CAGR and reach US$1.4 Billion by the end of ... Read More
-
Contraceptives
... 6.3% over the analysis period 2024-2030. Drugs, one of the segments analyzed in the report, is expected to record a 6.8% CAGR and reach US$26.0 Billion by the end of the analysis period. Growth in ... Read More
-
Medicated Skin Care Products
... 2030, growing at a CAGR of 3.1% over the analysis period 2024-2030. Cleansers, one of the segments analyzed in the report, is expected to record a 2.9% CAGR and reach US$2.9 Billion by the end ... Read More
-
OTC Dry Eye Drops Global Market Report 2025
... eye drops market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond. Reasons to Purchase Gain a truly ... Read More
-
Motion Sickness Treatment
... at a CAGR of 2.0% over the analysis period 2024-2030. Anticholinergic, one of the segments analyzed in the report, is expected to record a 2.2% CAGR and reach US$532.7 Million by the end of the ... Read More
-
Throat Lozenges
... CAGR of 4.8% over the analysis period 2024-2030. Hard Candy, one of the segments analyzed in the report, is expected to record a 5.2% CAGR and reach US$4.9 Billion by the end of the analysis ... Read More
-
Belgium Pharmaceuticals - Industry Report
... attractive acquisition opportunities • Analyse industry trends • Benchmark their own financial performance Using an exclusive methodology, a quick glance of this Pharmaceuticals (Belgium) report will tell you the companies that have a declining financial ... Read More
-
India Pharmaceuticals and Medicine - Industry Report
... Seek out the most attractive acquisition opportunities • Analyse industry trends • Benchmark their own financial performance Using an exclusive methodology, a quick glance of this Pharmaceuticals and Medicine (India) report will tell you the ... Read More
-
Active Pharmaceutical Ingredients (API)
... 2030, growing at a CAGR of 6.3% over the analysis period 2024-2030. Innovative, one of the segments analyzed in the report, is expected to record a 6.0% CAGR and reach US$240.8 Billion by the end ... Read More
-
Ginseng
... 10.2% over the analysis period 2024-2030. Asian Ginseng, one of the segments analyzed in the report, is expected to record a 10.0% CAGR and reach US$11.2 Billion by the end of the analysis period. Growth ... Read More
-
Cold and Flu Supplements
... 2030, growing at a CAGR of 5.1% over the analysis period 2024-2030. Vitamins & Minerals, one of the segments analyzed in the report, is expected to record a 4.8% CAGR and reach US$10.8 Billion by ... Read More
-
First Aid Kits
... at a CAGR of 6.2% over the analysis period 2024-2030. Common Type Kit, one of the segments analyzed in the report, is expected to record a 6.2% CAGR and reach US$189.1 Million by the end ... Read More
-
Herbal Supplements and Remedies
... 2030, growing at a CAGR of 8.7% over the analysis period 2024-2030. Multi-Herbs, one of the segments analyzed in the report, is expected to record a 9.4% CAGR and reach US$94.2 Billion by the end ... Read More
-
Cold, Cough, And Sore Throat Remedies
... reach US$9.7 Billion by 2030, growing at a CAGR of 5.2% over the analysis period 2024-2030. Syrups & Drops, one of the segments analyzed in the report, is expected to record a 5.6% CAGR and ... Read More
-
Antacids
... 2.2% over the analysis period 2024-2030. Proton Pump Inhibitors, one of the segments analyzed in the report, is expected to record a 3.6% CAGR and reach US$2.2 Billion by the end of the analysis period. ... Read More
-
Carotenoids
... 3.8% over the analysis period 2024-2030. Beta-Carotene, one of the segments analyzed in the report, is expected to record a 4.6% CAGR and reach US$1.1 Billion by the end of the analysis period. Growth in ... Read More
-
Analgesics
... 5.3% over the analysis period 2024-2030. Prescription, one of the segments analyzed in the report, is expected to record a 5.0% CAGR and reach US$43.8 Billion by the end of the analysis period. Growth in ... Read More
-
Human Reproductive Technologies
... at a CAGR of 2.2% over the analysis period 2024-2030. Contraceptive Drugs & Devices, one of the segments analyzed in the report, is expected to record a 2.5% CAGR and reach US$22.0 Billion by the ... Read More
-
Insomnia Drugs
... CAGR of 5.8% over the analysis period 2024-2030. Prescription Sleep Aids, one of the segments analyzed in the report, is expected to record a 5.3% CAGR and reach US$4.5 Billion by the end of the ... Read More
Research Assistance
